Bottles of Mystic Shield Protection Topical Solution hand sanitizer are recalled because they contain undeclared methanol, also known as wood alcohol, which can be toxic if absorbed through the skin or ingested. The products are packaged in 8.45-ounce (250ml) bottles and manufactured by Mystic Intl S.A. de C.V. in Mexico City. The recall was issued by Transliquid Technologies LLC.
According to the company’s news release, “Substantial methanol exposure ‘could result in nausea, vomiting, headache, blurred vision, permanent blindness, seizures, coma, permanent damage to the nervous system, or death. Although all persons using these products on their hands are at risk, young children who accidentally ingest these products, and adolescents and adults who drink these products as an alcohol substitute, are most at risk for methanol poisoning.” To date, Transliquid Technologies LLC has not received any reports of adverse events related to this issue.
Mystic Shield Protection Topical Solution is an alcohol-based hand sanitizer used to reduce potential disease-causing bacteria when soap and water are not available. The hand sanitizers were distributed between May 21, 2020 and June 30, 2020, to wholesale and retail customers in California, Louisiana, Massachusetts and Texas.
Last month, the Food and Drug Administration (FDA) warned consumers not to use any hand sanitizers manufactured in Mexico by Eskbiochem Sa de CV because they contain methanol. A total of nine products were listed in the agency’s news release. The FDA contacted Eskbiochem and recommended it remove the hand sanitizer from the market due to the risk to consumers, but the company had not responded.
After discovering the undeclared methanol in its hand sanitizers, Transliquid Technologies LLC, agreed to recall its products. The company is notifying its distributors and customers by email and mail and is arranging for the return of all recalled products. Anyone who has Muystic Shield Protection hand sanitizer should stop using it immediately. Consumers should contact their doctors if they have experienced any problems that may be related to taking or using these products.
Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.